These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1233 related items for PubMed ID: 9476189
1. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy. Mazzaro C, Carniello GS, Colle R, Doretto P, Mazzi G, Crovatto M, Santini GF, Tulissi P, Gregoretti M, Mazzoran L, Russo A, Silvestri F, Pozzato G. Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189 [Abstract] [Full Text] [Related]
2. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy. Mazzaro C, Franzin F, Tulissi P, Pussini E, Crovatto M, Carniello GS, Efremov DG, Burrone O, Santini G, Pozzato G. Cancer; 1996 Jun 15; 77(12):2604-13. PubMed ID: 8640712 [Abstract] [Full Text] [Related]
3. Long-term effects of alpha-interferon therapy for type II mixed cryoglobulinemia. Mazzaro C, Pozzato G, Moretti M, Crovatto M, Modolo ML, Mazzi G, Santini G. Haematologica; 1994 Jun 15; 79(4):342-9. PubMed ID: 7528704 [Abstract] [Full Text] [Related]
4. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications. Olaso V, Córdoba J, Berenguer M, Prieto M, Lainez B, Argüello L, Valverde J, Pascual S, Gobernado M, Berenguer J. Rev Esp Enferm Dig; 1997 Jul 15; 89(7):531-50. PubMed ID: 9265839 [Abstract] [Full Text] [Related]
6. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thibault V, Ghillani P, Myers RP, Leger JM, Servan J, Piette JC. Arthritis Rheum; 2002 Dec 15; 46(12):3317-26. PubMed ID: 12483738 [Abstract] [Full Text] [Related]
7. Hepatitis C virus infection and cryoglobulinaemia. Lunel F, Musset L. Forum (Genova); 1998 Dec 15; 8(1):95-103. PubMed ID: 9514994 [Abstract] [Full Text] [Related]
8. Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C. De Mitri MS, Morsica G, Chen CH, Mele L, Baccarini P, Chianese R, Piccinini A, Lazzarin A, Pisi E. Ital J Gastroenterol Hepatol; 1997 Jun 15; 29(3):255-61. PubMed ID: 9646218 [Abstract] [Full Text] [Related]
9. Pilot study on the safety and efficacy of intravenous natural beta-interferon therapy in patients with chronic hepatitis C unresponsive to alpha-interferon. Mazzoran L, Grassi G, Giacca M, Gerini U, Baracetti S, Fanni-Canelles M, Zorat F, Pozzato G. Ital J Gastroenterol Hepatol; 1997 Aug 15; 29(4):338-42. PubMed ID: 9476188 [Abstract] [Full Text] [Related]
10. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children. Czerwionka-Szaflarska M, Chrobot A, Szaflarska-Szczepanik A. Med Sci Monit; 2000 Aug 15; 6(5):964-70. PubMed ID: 11208439 [Abstract] [Full Text] [Related]
11. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response. Landau DA, Saadoun D, Halfon P, Martinot-Peignoux M, Marcellin P, Fois E, Cacoub P. Arthritis Rheum; 2008 Feb 15; 58(2):604-11. PubMed ID: 18240235 [Abstract] [Full Text] [Related]
12. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection. Weiland O, Chen M, Lindh G, Mattsson L, Schvarcz R, Sönnerborg A, Wahl M, Wejstål R, Widell A, Norkrans G. Scand J Infect Dis; 1995 Feb 15; 27(4):319-24. PubMed ID: 8658063 [Abstract] [Full Text] [Related]
13. Long-term follow-up after successful interferon therapy of acute hepatitis C. Wiegand J, Jäckel E, Cornberg M, Hinrichsen H, Dietrich M, Kroeger J, Fritsch WP, Kubitschke A, Aslan N, Tillmann HL, Manns MP, Wedemeyer H. Hepatology; 2004 Jul 15; 40(1):98-107. PubMed ID: 15239091 [Abstract] [Full Text] [Related]
14. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases. Bayraktar Y, Bayraktar M, Gurakar A, Hassanein TI, Van Thiel DH. Hepatogastroenterology; 1997 Jul 15; 44(14):417-25. PubMed ID: 9164512 [Abstract] [Full Text] [Related]
15. Parameters predicting response to alpha-interferon treatment in chronic hepatitis C. Glück T, Seelig R, Dette S, Bühring HJ, Renz M, Kwon S, Wiedmann KH, Weber P. Hepatogastroenterology; 1997 Jul 15; 44(14):484-91. PubMed ID: 9164523 [Abstract] [Full Text] [Related]
16. Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus. Nakamura H, Ogawa H, Kuroda T, Yamamoto M, Enomoto H, Kishima Y, Yoshida K, Ito H, Matsuda M, Noguchi S. Hepatogastroenterology; 2002 Jul 15; 49(47):1373-6. PubMed ID: 12239945 [Abstract] [Full Text] [Related]
17. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients. Canavese C, Hollò Z, Ciccone G, Ghisetti V, Barbui A, Fop F, Martina G, Forgnone F, Novo P, Thea A, Grill A, Marchiaro G. J Nephrol; 2000 Jul 15; 13(5):352-9. PubMed ID: 11063139 [Abstract] [Full Text] [Related]
19. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy. Shindo M, Ken A, Okuno T. Cancer; 1999 May 01; 85(9):1943-50. PubMed ID: 10223234 [Abstract] [Full Text] [Related]
20. [Predictive value of a rapid negativity of serum virus C viremia during treatment with interferon alpha in patients with chronic hepatitis C]. Moulin V, Harzic M, Doll J, Dubeaux B, Ghnassia JC, Andrieu J. Pathol Biol (Paris); 1996 May 01; 44(5):468-72. PubMed ID: 8758497 [Abstract] [Full Text] [Related] Page: [Next] [New Search]